Viavi officer plans $2.04M stock sale in 2026

VIAVI SOLUTIONS INC.

Rhea-AI Filing Summary

VIAVI SOLUTIONS INC. (VIAV) received a notice under Rule 144 that officer Ilan Daskal plans to sell 56,290 shares of common stock through Morgan Stanley Smith Barney LLC. The planned sale has an aggregate market value of $2,042,488.28, with an approximate sale date of 08/31/2026 on NASDAQ. The securities consist of restricted stock acquired from the issuer in two blocks of 30,257 and 26,033 shares.

Key Figures

Shares to be sold: 56,290 shares of common stock Aggregate market value: $2,042,488.28 Shares outstanding: 246,749,828 shares +3 more

6 metrics

Shares to be sold 56,290 shares of common stock Number of shares to be sold under Rule 144

Aggregate market value $2,042,488.28 Value of the 56,290 shares to be sold

Shares outstanding 246,749,828 shares Common shares outstanding referenced in the filing

Block 1 restricted shares 30,257 shares First block of restricted stock to be sold

Block 2 restricted shares 26,033 shares Second block of restricted stock to be sold

Approximate date of sale 08/31/2026 Planned sale date for the Rule 144 transaction

Key Terms

Rule 144, Restricted Stock, Aggregate market value, Approximate date of sale

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 08/28/2026 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 56290 | 2042488.28"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Approximate date of sale financial

"Common | Morgan Stanley Smith Barney LLC ... | 246749828 | 08/31/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for VIAV?

The filing discloses that officer Ilan Daskal plans to sell 56,290 shares of VIAVI common stock under Rule 144, with an aggregate market value of $2,042,488.28, through Morgan Stanley Smith Barney LLC, targeting an approximate sale date of 08/31/2026 on NASDAQ.

How many VIAV shares are planned to be sold by Ilan Daskal?

Ilan Daskal plans to sell 56,290 shares of VIAVI SOLUTIONS INC. common stock. The shares are reported as restricted stock, split into two blocks of 30,257 and 26,033 shares sourced from the issuer.

What is the value of the VIAV shares covered by this Form 144?

The planned sale of VIAVI common stock has an aggregate market value of $2,042,488.28, as reported in the Form 144. This value corresponds to the 56,290 shares proposed to be sold under Rule 144.

When is the approximate sale date for the VIAV shares on this Form 144?

The approximate sale date for the VIAVI common shares covered by this Form 144 is 08/31/2026. The filing also notes separate dates of 08/28/2026 associated with the two restricted stock blocks to be sold.

On which exchange are the VIAV shares expected to be sold?

The VIAVI SOLUTIONS INC. common shares referenced in this Form 144 are expected to be sold on NASDAQ, as indicated in the securities information section of the filing.

How many VIAV shares were outstanding as referenced in the Form 144?

The Form 144 references 246,749,828 VIAVI common shares outstanding. This figure is provided as context for the planned sale of 56,290 shares under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 04:07 PM EDT Accepted by SEC EDGAR 08/31/2026 - 04:05 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001446964
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VIAVI SOLUTIONS INC.
SEC File Number	000-22874
Address of Issuer	1445 South Spectrum Blvd Suite 102 Chandler ARIZONA 85286
Phone	(408) 404-3600
Name of Person for Whose Account the Securities are To Be Sold	ILAN DASKAL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	56290	2042488.28	246749828	08/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/28/2026	Restricted Stock	Issuer			30257	08/28/2026	Not Applicable
Common	08/28/2026	Restricted Stock	Issuer			26033	08/28/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Ilan Daskal
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)